Oxford Cancer Biomarkers Partners with Mason-Based Mira Precision Health to Advance its ToxNav® Test for Predicting Patient Toxicity to 5FU/capecitabine Treatment in the USA
05/30/25 – Mira Precision ToxNav® Test becomes excellent addition to the City of Mason’s technology portfolio